…
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company distributes capital equipment, medical consumables, and online procurement solutions for hospitals, as well as offers pharmacy products, dispensary supplies, private label solutions, and digital ordering platforms to pharmacies, pharmacy groups, and hospital pharmacy services; medical consumables, nutrition supplies, aged care equipment, resident safety technology, and digital procurement solutions; and orthopedic implants, surgical technologies, and patient-focused solutions for orthopedic surgeons, hospitals, and healthcare providers. It also offers ophthalmic and optometry equipment, including diagnostic devices, OCT systems, slit lamps, dry eye treatment solutions, surgical instruments, and vision testing tools for eye care professionals and day surgery facilities; treatment room consumables, vaccines, diagnostic equipment, and infection prevention products for general practices, medical centres, and community healthcare providers; dental consumables, infection control supplies, dental equipment, imaging and technical support; laboratory equipment, scientific consumables, diagnostic instruments, and technical support; and diagnostic technologies, laboratory systems, and technical expertise. In addition, the company offers medical devices and clinical consumables; digital x-ray, ultrasound, molecular imaging, mobile c-arm, imaging navigation systems, and AI-driven software solutions; vitamins, supplements, herbal, and naturopathic products; veterinary consumables, pharmaceuticals, diagnostic equipment, and specialist clinical products; aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; and surgical robotics and robotic-assisted surgical systems hospitals and healthcare facilities. The company is based in Mount Waverley, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Paragon Care Ltd supplies and services medical equipment and consumables to hospitals, aged-care and other healthcare providers, primarily in Australia. Long-term growth may be supported by ageing populations, rising healthcare spending and growing demand for equipment lifecycle services, while recurring service and consumables revenue could provide some stability.
Material risks include dependence on public-sector procurement cycles, strong competition from larger medtech distributors, supply-chain constraints and execution risks that could compress margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -21.67M | 25.46M | 14.05M | 20.85M | 10.69M |
| Minority interest | - | - | - | -2.80M | -0.51M |
| Net income | -16.03M | 20.57M | 8.38M | 10.76M | 6.63M |
| Selling general administrative | - | 38.22M | 87.24M | 70.09M | 60.12M |
| Selling and marketing expenses | - | 54.36M | 42.33M | 11.21M | 8.70M |
| Gross profit | 157.46M | 324.00M | 176.07M | 126.32M | 102.83M |
| Reconciled depreciation | - | - | 14.47M | 10.29M | 7.98M |
| Ebit | 6.42M | 59.98M | 28.71M | 27.56M | 20.99M |
| Ebitda | 43.70M | 89.81M | 43.18M | 37.86M | 28.97M |
| Depreciation and amortization | 37.27M | 29.83M | 14.47M | 10.29M | 7.98M |
| Operating income | 6.42M | 89.53M | 28.44M | 23.26M | 13.29M |
| Other operating expenses | 3674.12M | 3524.36M | 2921.52M | 83.31M | 59.53M |
| Interest expense | 35.22M | 33.17M | 16.24M | 5.93M | 5.70M |
| Tax provision | - | 4.89M | 5.67M | 5.20M | 3.54M |
| Interest income | - | 25.96M | 1.63M | 0.38M | 0.13M |
| Net interest income | - | - | -14.61M | -6.64M | -5.98M |
| Extraordinary items | - | - | - | -2.09M | - |
| Income tax expense | -5.64M | 4.89M | 5.67M | 5.20M | 3.54M |
| Total revenue | 3680.54M | 3613.89M | 2969.89M | 307.63M | 247.91M |
| Total operating expenses | 151.04M | 234.47M | 127.70M | 102.22M | 84.12M |
| Cost of revenue | 3523.08M | 3289.89M | 2793.82M | 181.31M | 145.08M |
| Total other income expense net | -28.10M | -64.07M | -14.39M | 3.39M | -2.05M |
| Discontinued operations | - | - | - | -2.09M | 0.34M |
| Net income from continuing ops | - | - | 8.38M | 15.65M | 7.14M |
| Net income applicable to common shares | - | 20.57M | 6.75M | 10.76M | 6.63M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 1373.36M | 1234.05M | 1130.89M | 448.52M | 437.03M |
| Intangible assets | 116.29M | 384.64M | - | 6.73M | 3.36M |
| Other current assets | 43.02M | 52.63M | 3.26M | 1.73M | 9.20M |
| Total liab | 1077.48M | 915.04M | 838.97M | 196.56M | 194.69M |
| Total stockholder equity | 295.88M | 319.00M | 291.92M | 242.85M | 236.03M |
| Other current liab | 40.86M | 22.93M | 22.55M | 29.03M | 27.52M |
| Common stock | 328.49M | 328.49M | 328.49M | 232.30M | 228.66M |
| Capital stock | - | - | - | 232.30M | 228.66M |
| Retained earnings | -31.90M | -15.87M | -36.24M | 10.10M | 7.53M |
| Other liab | - | - | - | 2.59M | 2.26M |
| Good will | 333.42M | - | - | 252.33M | 241.02M |
| Other assets | - | - | 0.00M | 9.72M | 11.31M |
| Cash | 23.68M | 21.90M | 19.94M | 22.60M | 46.20M |
| Total current liabilities | 884.33M | 647.64M | 701.92M | 93.55M | 87.38M |
| Current deferred revenue | 5.32M | - | 9.48M | 6.16M | 10.10M |
| Net debt | 365.23M | 274.62M | 231.88M | 99.54M | 85.06M |
| Short term debt | 237.00M | 47.50M | 116.75M | 21.72M | 26.21M |
| Short long term debt | - | - | - | 17.09M | 22.69M |
| Short long term debt total | 388.90M | 296.52M | 251.83M | 122.14M | 131.26M |
| Other stockholder equity | -0.71M | - | -0.33M | -242.40M | -236.18M |
| Property plant equipment | - | - | - | 44.92M | 30.50M |
| Total current assets | 779.56M | 759.79M | 681.52M | 132.65M | 150.84M |
| Long term investments | - | - | - | 2.17M | 0.26M |
| Net tangible assets | - | - | - | -16.21M | -8.35M |
| Net receivables | 370.73M | 402.71M | 350.58M | 39.43M | 42.92M |
| Long term debt | - | - | - | 67.60M | 73.40M |
| Inventory | 342.13M | 282.54M | 307.74M | 63.69M | 51.45M |
| Accounts payable | 601.15M | 577.21M | 553.13M | 36.65M | 23.56M |
| Accumulated other comprehensive income | - | 6.39M | - | 10.55M | 7.38M |
| Non currrent assets other | 11.11M | 11.12M | 6.08M | - | - |
| Non current assets total | 593.80M | 474.26M | 449.37M | 315.87M | 286.19M |
| Capital lease obligations | - | - | - | 37.45M | 35.18M |
| Long term debt total | - | - | - | 100.42M | 105.05M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | - | -19.52M | -31.75M | 7.07M |
| Change to liabilities | - | - | - | 3.68M | -14.96M |
| Total cashflows from investing activities | -83.04M | -16.64M | -19.52M | -31.75M | 7.07M |
| Net borrowings | - | - | 13.07M | -15.72M | -11.45M |
| Total cash from financing activities | 59.42M | 28.65M | -5.95M | -10.00M | -11.93M |
| Change to operating activities | - | - | - | -1.06M | -4.59M |
| Net income | -16.03M | 20.57M | 8.38M | 10.76M | 6.09M |
| Change in cash | 3.35M | 1.95M | 18.97M | -23.60M | 13.01M |
| Begin period cash flow | 20.33M | 19.94M | 0.97M | 46.20M | 33.20M |
| End period cash flow | 23.68M | 21.90M | 19.94M | 22.60M | 46.20M |
| Total cash from operating activities | 29.09M | -11.35M | 44.45M | 17.75M | 19.03M |
| Issuance of capital stock | - | - | - | 0.42M | 0.48M |
| Depreciation | 37.27M | 29.83M | 14.47M | 8.86M | 7.94M |
| Other cashflows from investing activities | - | -4.49M | -12.40M | -10.70M | -1.49M |
| Dividends paid | - | 0.00M | 12.61M | 7.89M | 1.04M |
| Change to inventory | - | -10.14M | -6.11M | -12.43M | 8.29M |
| Change to account receivables | - | -53.55M | -97.86M | -1.10M | 7.72M |
| Sale purchase of stock | - | - | - | -0.02M | -0.02M |
| Other cashflows from financing activities | -13.31M | -0.00M | -7.98M | 7.46M | -2.49M |
| Change to netincome | - | - | - | 3.25M | 7.32M |
| Capital expenditures | 30.58M | 11.69M | 19.32M | 21.05M | 4.61M |
| Change in working capital | - | -80.63M | 19.70M | -13.53M | -5.16M |
| Stock based compensation | - | 0.98M | - | 0.35M | 0.85M |
| Other non cash items | 7.85M | 17.89M | 1.90M | -1.87M | 7.14M |
| Free cash flow | -1.49M | -23.04M | 25.14M | -3.30M | 14.42M |
Sector: Healthcare Industry: Medical Distribution
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PGC Paragon Care Ltd |
-0.01 3.23% |
0.15 | - | 5.98 | 0.07 | 0.84 | 0.17 | 13.27 |
| SIG Sigma Healthcare Ltd |
- -% |
2.82 | 47.00 | 32.15 | 3.00 | 6.45 | 3.15 | 30.00 |
| EBO Ebos Group Ltd |
-0.11 0.63% |
17.29 | 15.13 | 18.08 | 0.27 | 1.34 | 0.39 | 9.21 |
| MYX Mayne Pharma Group Ltd |
0.37 13.65% |
3.08 | 8.74 | 263.16 | 0.58 | 0.55 | 0.47 | 1.28 |
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company distributes capital equipment, medical consumables, and online procurement solutions for hospitals, as well as offers pharmacy products, dispensary supplies, private label solutions, and digital ordering platforms to pharmacies, pharmacy groups, and hospital pharmacy services; medical consumables, nutrition supplies, aged care equipment, resident safety technology, and digital procurement solutions; and orthopedic implants, surgical technologies, and patient-focused solutions for orthopedic surgeons, hospitals, and healthcare providers. It also offers ophthalmic and optometry equipment, including diagnostic devices, OCT systems, slit lamps, dry eye treatment solutions, surgical instruments, and vision testing tools for eye care professionals and day surgery facilities; treatment room consumables, vaccines, diagnostic equipment, and infection prevention products for general practices, medical centres, and community healthcare providers; dental consumables, infection control supplies, dental equipment, imaging and technical support; laboratory equipment, scientific consumables, diagnostic instruments, and technical support; and diagnostic technologies, laboratory systems, and technical expertise. In addition, the company offers medical devices and clinical consumables; digital x-ray, ultrasound, molecular imaging, mobile c-arm, imaging navigation systems, and AI-driven software solutions; vitamins, supplements, herbal, and naturopathic products; veterinary consumables, pharmaceuticals, diagnostic equipment, and specialist clinical products; aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; and surgical robotics and robotic-assisted surgical systems hospitals and healthcare facilities. The company is based in Mount Waverley, Australia.
77-97 Ricketts Road, Mount Waverley, VIC, Australia, 3149
61 3 8833 7800
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark Robert Hooper BBus (Acc), C.P.A., CPA, FFTP, M.A.I.C.D., MAICD | Group CEO, MD & Director | 1959 |
| Mr. Stephen J. Munday | Exec. Officer | 1964 |
| Mr. John Andrew Walstab | Exec. Director & Exec. GM of Paragon Care Asia | 1963 |
| Ms. Josephine De Martino | Chief Financial Officer | NA |
| Ms. Melanie Jaye Leydin B.Bus, C.A., CA | Joint Company Sec. | 1973 |
| Ms. Claire Newstead-Sinclair BBus, C.A., CA | Joint Company Sec. | NA |
| Mr. Michael G. Rice | Group Commercial Mang. | 1976 |
| Mr. John Andrew Walstab | Group CEO, MD & Executive Director | 1963 |
| Ms. Melanie Jaye Leydin B.Bus, C.A. | Joint Company Secretary | 1973 |
| Ms. Claire Newstead-Sinclair BBus, C.A., CA | Joint Company Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.